The innovative echocardiography software platform "CAAS Qardia" by Pie Medical Imaging receives medical device certification in Japan

PIE MEDICAL IMAGING

PR99983

 

MAASTRICHT, Netherlands, April 24, 2023 /PRNewswire=KYODO JBN/--

 

Pie Medical Imaging, a global leader in cardiac imaging, announced it has

received NINSHO Medical Device Certification for CAAS Qardia, their innovative

echocardiography software platform.

 

This recent certification of CAAS Qardia gives Japanese healthcare institutions

and companies access to a complete and flexible solution for off-cart viewing,

analysis, and reporting.

 

CAAS Qardia excels at myocardial strain analysis, stress-echo, diastolic

function assessment, and (PISA) valve analysis. CAAS Qardia leverages

artificial intelligence-driven workflows automating key clinical measurements

and ease of access.

 

CAAS Qardia transforms off-cart echocardiogram analysis by offering besides

standalone use a unique zero-footprint deployment roll-out, meaning access from

any computer within the hospital network via a web browser.

 

The advent of vendor-independent automated calculation of myocardial strain,

and in special its primary clinical parameter, global longitudinal strain

(GLS), supports improved characterization of cardiac function.

 

Dr Ernest Spitzer, Chief Medical Officer of Cardialysis Core Laboratory,

Rotterdam, The Netherlands, and first author of the recently published CAAS

Qardia myocardial strain validation paper*, said: "Beyond the implementation of

a standardized method, the use of automation may soon expedite the increased

use of quantitative parameters in clinical routine."

 

Findings as presented in the paper by Dr Spitzer and colleagues include that:

 

- Measurement of endocardial GLS using a CAAS Qardia is feasible and yields

comparable results when compared with commercially available desktop software.

- The inter- and intra- observer reproducibility with CAAS Qardia, are

comparable (if not superior) to those with commercially available desktop

software.

 

Rene Guillaume, Managing Director of Pie Medical Imaging said: "With this

certification of CAAS Qardia, an easy-to-use and accurate tool becomes

available for Japanese healthcare institutions."

 

*Spitzer et al. "Echocardiography Core Laboratory Validation of a Novel

Vendor-Independent Web-Based Software for the Assessment of Left Ventricular

Global Longitudinal Strain". Journal of Cardiovascular Imaging 2023;31:e20.

https://doi.org/10.4250/jcvi.2022.0130.

 

About Pie Medical Imaging

 

Pie Medical Imaging BV is a world leader in analysis and visualization of

cardiovascular images in Maastricht (The Netherlands), it hosts the global

sales for the CAAS and 3mensio product lines. PMI and 3mensio Medical Imaging

are part of the Esaote Group, leader in the biomedical equipment sector, in

particular the areas of ultrasound, dedicated MRI and Medical IT.  More

information about PMI is available at www.piemedicalimaging.com

 

Photo: https://mma.prnewswire.com/media/2060187/CAAS_Qardia.jpg

Logo: https://mma.prnewswire.com/media/2059701/PIE_MEDICAL_IMAGING_Logo.jpg

 

Source - PIE MEDICAL IMAGING

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中